{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T17:10:20Z","timestamp":1707930620266},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,5,30]],"date-time":"2007-05-30T00:00:00Z","timestamp":1180483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,5,30]],"date-time":"2007-05-30T00:00:00Z","timestamp":1180483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Nutr"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1038\/sj.ejcn.1602793","type":"journal-article","created":{"date-parts":[[2007,5,30]],"date-time":"2007-05-30T12:25:14Z","timestamp":1180527914000},"page":"1031-1037","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Uridine supplementation in HIV lipoatrophy: pilot trial on safety and effect on mitochondrial indices"],"prefix":"10.1038","volume":"62","author":[{"given":"G A","family":"McComsey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"O'Riordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Setzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Lebrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U A","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,5,30]]},"reference":[{"key":"BF1602793_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/01.qai.0000187137.34789.dd","volume":"40","author":"P Bacchetti","year":"2005","unstructured":"Bacchetti P, Gripshover B, Grunfeld C, Heymsfield S, McCreath H, Osmond D et al. Study of fat redistribution and metabolic change in HIV infection (FRAM) (2005) Fat distribution in men with HIV infection. J Acquir Immune Defic Syndr 40, 119\u2013120.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"BF1602793_CR2","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1042\/bj3050817","volume":"305","author":"AG Bodnar","year":"1995","unstructured":"Bodnar AG, Cooper JM, Leonard JV, Schapira AH (1995). Respiratory-deficient human fibroblasts exhibiting defective mitochondrial DNA replication. Biochem J 305, 817\u2013822.","journal-title":"Biochem J"},{"key":"BF1602793_CR3","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1182\/blood.V76.11.2210.2210","volume":"76","author":"P Calabresi","year":"1990","unstructured":"Calabresi P, Falcone A, St Clair MH, Wiemann MC, Chu SH, Darnowski JW, For the trial to assess the regression of hyperlactatemia to evaluate the regression of established lipodystrophy in HIV-1-positive subjects (TARHEEL; ESS40010) Study Team (1990). Benzylacyclouridine reverses azidothymidine-induced marrow suppression without impairment of anti-human immunodeficiency virus activity. Blood 76, 2210\u20132215.","journal-title":"Blood"},{"key":"BF1602793_CR4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1006\/clim.1999.4777","volume":"93","author":"RI Fox","year":"1999","unstructured":"Fox RI, Herrmann ML, Frangou CG, Wahl GM, Morris RE, Strand V et al. (1999). Mechanism of action of leflunamide in rheumatoid arthritis. Clin Immunol 93, 198\u2013208.","journal-title":"Clin Immunol"},{"key":"BF1602793_CR5","unstructured":"http:\/\/aactg.s-3.com\/members\/download\/other\/Metabolic\/VenousLactateSOP.doc."},{"key":"BF1602793_CR6","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1097\/00002030-200212060-00010","volume":"16","author":"V Joly","year":"2002","unstructured":"Joly V, Flandre P, Meiffredy V, Leturque N, Harel M, Aboulker JP et al. (2002). Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial. AIDS 16, 2447\u20132454.","journal-title":"AIDS"},{"key":"BF1602793_CR7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/135965350300800516","volume":"8","author":"EC Koch","year":"2003","unstructured":"Koch EC, Schneider J, Weiss R, Penning B, Walker UA (2003). Uridine excess does not interfere with the antiretroviral efficacy of nucleoside analogue reverse transcriptase inhibitors. Antivir Ther 8, 485\u2013487.","journal-title":"Antivir Ther"},{"key":"BF1602793_CR8","first-page":"5928","volume":"44","author":"A Leyva","year":"1984","unstructured":"Leyva A, van Groeningen CJ, Kraal I, Gall H, Peters GJ, Lankelma J, et al., the Rave Study Group (1984). Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity. Cancer Res 44, 5928\u20135933.","journal-title":"Cancer Res"},{"key":"BF1602793_CR9","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1097\/00002030-200007070-00002","volume":"10","author":"SA Mallal","year":"2000","unstructured":"Mallal SA, John M, Moore CB, James IR, McKinnon EJ, the Adult AIDS Clinical Trials Group (2000). Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS 14 10, 1309\u20131316.","journal-title":"AIDS"},{"key":"BF1602793_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1023\/A:1005357622551","volume":"20","author":"FR Manis","year":"1997","unstructured":"Manis FR, Cohn LB, McBride-Chang C, Wolff JA, Kaufman FR (1997). A longitudinal study of cognitive functioning in patients with classical galactosemia, including a cohort treated with oral uridine. J Inherit Metab Dis 20, 549\u2013555.","journal-title":"J Inherit Metab Dis"},{"key":"BF1602793_CR11","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1128\/AAC.38.12.2743","volume":"38","author":"JL Martin","year":"1994","unstructured":"Martin JL, Brown CE, Matthews-Davis N, Reardon JE (1994). Effects of antiviral nucleoside analogues on human DNA polymerases and mitochondrial DNA synthesis. Antimicrob Agents Chemother 38, 2743\u20132749.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF1602793_CR12","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/00002030-200404300-00011","volume":"18","author":"A Martin","year":"2004","unstructured":"Martin A, Smith D, Carr A, Ringland C, Amin J, Emery S et al. (2004). Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study. AIDS 18, 1029\u20131036.","journal-title":"AIDS"},{"key":"BF1602793_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985). Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412\u2013419.","journal-title":"Diabetologia"},{"key":"BF1602793_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1086\/380790","volume":"38","author":"GA McComsey","year":"2004","unstructured":"McComsey GA, Ward DJ, Hessenthaler SM, Sension MG, Shalit P, Lonergan TJ et al. (2004). Improvement in HAART-associated lipoatrophy in HIV-infected patients switched from stavudine to abacavir or zidovudine: The results of TARHEEL. Clin Infect Dis 38, 263\u2013270.","journal-title":"Clin Infect Dis"},{"key":"BF1602793_CR15","unstructured":"McComsey GA, O\u2019Riordan M, Storer N, Goldman S, Ganz J, Libutti DE et al. (2005). Clinical lipoatrophy assessment strongly correlates with DEXA-measured limb fat and subcutaneous fat mitochondrial DNA levels. Abstract 142 Program and Abstracts of the 13th Conference on Retroviruses and Opportunistic Infections 5\u20139 February 2005; Denver, Colorado."},{"key":"BF1602793_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00002030-200501030-00002","volume":"19","author":"GA McComsey","year":"2005","unstructured":"McComsey GA, Paulsen DM, Lonergan TJ, Hessenthaler SM, Hoppel CL, Williams VC et al. (2005). Improvements in lipoatrophy, mitochondrial DNA content and adipose tissue apoptosis levels after replacement of stavudine with either abacavir or zidovudine. AIDS 19, 15\u201323.","journal-title":"AIDS"},{"key":"BF1602793_CR17","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1097\/01.aids.0000247574.33998.03","volume":"20","author":"GJ Moyle","year":"2006","unstructured":"Moyle GJ, Sabin CA, Cartledge J, Johnson M, Wilkins E, Churchill D et al. RAVE (Randomized Abacavir versus Viread Evaluation) Group UK (2006). a randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy. AIDS 20, 2043\u20132050.","journal-title":"AIDS"},{"key":"BF1602793_CR18","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1097\/00002030-200306130-00007","volume":"17","author":"D Nolan","year":"2003","unstructured":"Nolan D, Hammond E, Martin A, Taylor L, Hermann S, McKinnon E et al. (2003). Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy. AIDS 17, 1329\u20131338.","journal-title":"AIDS"},{"key":"BF1602793_CR19","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1086\/427655","volume":"191","author":"B Setzer","year":"2005","unstructured":"Setzer B, Schlesier M, Walker UA (2005). Effects of didanosine-related depletion on mtDNA in human T lymphocytes. J Infect Dis 191, 848\u2013855.","journal-title":"J Infect Dis"},{"key":"BF1602793_CR20","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1128\/AAC.32.7.997","volume":"32","author":"JP Sommadossi","year":"1988","unstructured":"Sommadossi JP, Carlisle R, Schinazi RF, Zhou Z (1988). Uridine reverses the toxicity of 3\u2032-azido-3\u2032 deoxythymidine in normal human granulocyte-macrophage progenitor cells in vitro without impairment of antiretroviral activity. Antimicrob Agents Chemother 32, 997\u20131001.","journal-title":"Antimicrob Agents Chemother"},{"key":"BF1602793_CR21","unstructured":"Sutinen J, Walker UA, Sevastianova K, Hakkinen AM, Ristola M, Yki-Jarvinen H (2005). Uridine supplementation increases subcutaneous fat in patients with HAART-associated lipodystrophy: a randomized placebo controlled trial. Abstract 7 The 7th Workshop on Adverse Drug Reactions and Lipodystrophy in HIV 13\u201316 November 2005, Dublin, Ireland."},{"key":"BF1602793_CR22","unstructured":"Tebas P, Zhang J, Yarasheski K, Evans S, Fischl M, Shevitz A et al. (2005). Switch to a protease inhibitor-containing\/nucleoside reverse transcriptase inhibitor-sparing regimen increases appendicular fat and serum lipid levels without affecting glucose metabolism or bone mineral density. The results of a prospective randomized trial, ACTG 5125s. Program and abstracts of the 12th Conference on Retroviruses and Opportunistic Infections 22\u201325 February 2005; Boston, Massachusetts. Abstract 40."},{"key":"BF1602793_CR23","first-page":"745","volume":"70","author":"CJ van Groeningen","year":"1986","unstructured":"van Groeningen CJ, Leyva A, Kraal I, Peters GJ, Pinedo HM (1986). Clinical and pharmacokinetic studies of prolonged administration of high-dose uridine intended for rescue from 5-FU toxicity. Cancer Treat Rep 70, 745\u2013750.","journal-title":"Cancer Treat Rep"},{"key":"BF1602793_CR24","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/01.aids.0000166101.44262.52","volume":"19","author":"N Venhoff","year":"2005","unstructured":"Venhoff N, Zilly M, Lebrecht D, Schirmer D, Klinker H, Thoden J et al. (2005). Uridine pharmacokinetics of mitocnol a sugar cane extract. AIDS 19, 739\u2013740.","journal-title":"AIDS"},{"key":"BF1602793_CR25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/135965350601100109","volume":"11","author":"UA Walker","year":"2006","unstructured":"Walker UA, Auclair M, Lebrecht D, Kornprobst M, Capeau J, Caron M (2006). Uridine abrogates the adverse effects of antiretroviral pyrimidine analogues on adipose cell functions. Antivir Ther 11, 25\u201334.","journal-title":"Antivir Ther"},{"key":"BF1602793_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00042560-200202010-00002","volume":"29","author":"UA Walker","year":"2002","unstructured":"Walker UA, Bickel M, L\u00fctke Volksbeck SI, Ketelsen UP, Sch\u00f6fer H, Setzer B et al. (2002). Evidence of nucleoside analogue reverse transcriptase inhibitor-associated genetic and structural defects of mitochondria in adipose tissue of HIV-infected patients. J Acquir Immune Defic Syndr 29, 117\u2013121.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"BF1602793_CR27","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1097\/00002030-200404300-00025","volume":"18","author":"UA Walker","year":"2004","unstructured":"Walker UA, Langmann P, Miehle N, Zilly M, Klinker H, Petschner F (2004). Beneficial effects of oral uridine in mitochondrial toxicity. AIDS 18, 1085\u20131086.","journal-title":"AIDS"},{"key":"BF1602793_CR28","doi-asserted-by":"crossref","first-page":"M117","DOI":"10.1177\/135965350501002S13","volume":"10","author":"UA Walker","year":"2005","unstructured":"Walker UA, Venhoff N (2005). Uridine in the prevention and treatment of NRT1-induced mitochondrial toxicity. Antivir Ther 10, M117\u2013M123.","journal-title":"Antivir Ther"},{"key":"BF1602793_CR29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/135965350300800514","volume":"8","author":"UA Walker","year":"2003","unstructured":"Walker UA, Venhoff N, Koch E, Olschweski M, Schneider J, Setzer B (2003). Uridine abrogates mitochondrial toxicity related to nucleoside analogue reverse transcriptase inhibitors in HepG2 cells. Antivir Ther 8, 463\u2013470.","journal-title":"Antivir Ther"},{"key":"BF1602793_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/978-1-4684-8559-2_34","volume":"122B","author":"DR Webster","year":"1979","unstructured":"Webster DR, Simmonds HA, Potter CF, Becroft DM (1979). Purine and pyrimidine metabolism in hereditary orotic aciduria during a 15 year follow up study. Adv Exp Med Biol 122B, 203\u2013208.","journal-title":"Adv Exp Med Biol"}],"container-title":["European Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1602793","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1602793.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1602793.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T16:52:19Z","timestamp":1707929539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1602793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,30]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["BF1602793"],"URL":"https:\/\/doi.org\/10.1038\/sj.ejcn.1602793","relation":{},"ISSN":["0954-3007","1476-5640"],"issn-type":[{"value":"0954-3007","type":"print"},{"value":"1476-5640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,30]]},"assertion":[{"value":"21 December 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}